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Abstract 
Introduction: The origin of neonatal oocyte development is unknown. However, estrogen 
plays an essential role during development of the female reproductive system. Anastrozole is 
used as both ovulation stimulating and an anticancer drug. The aim of this study was to 
evaluate the impact of Anastrozole on follicular development and differentiation in mice. 
Materials and methods: In the present study, 30 adult female and 15 adult male mice were 
used. Then, two female mice (at their sterous cycle) were kept with one male mouse in a cage 
for mating. After observing the vaginal plug (considered as first day of pregnancy) female 
mice were divided into two groups of control and experimental. In the experimental group, on 
the 14th day of pregnancy the mice received anastrozole (50 mg/Kg, i.p. injection). After 
delivery 16 pups were selected in each group.  Then 2, 4 and 7 day pups   were studies for 
primordial, primary and growing follicles number. 
Results: According to the morphometric studies, in the 2 day pup, the breakdown was not 
complete in treatment group. However, the number of primordial, primary and growing 
follicles of 4 and 7 day pups were not significantly difference in the control and experimental 
groups. 
Conclusion: According to the studies, estrogen is necessary for follicular breakdown and 
maternal anastrozole can reduce the primordial follicles. However, maternal anastrozole and 
estrogen depression couldn‟t effect on the histology of ovarian follicle in neonatal mouse. 
Keywords: Anastrozole, Ovarian follicles, Neonatal mouse, Histology 
Introduction 
In ovarian differentiation of female mouse, 
the clusters are the place of germ cells and 
were called oocyte nest or germline cysts. 
Mouse germ cells in clusters develop and 
dissociate after birth and an individual 
oocytes are surrounded by somatic 
pregranulosa cells and forming primordial 
follicles (1). Two thirds of the oocytes die 
by the mechanism of apoptosis, at the 
same time (2). In this way, in the neonatal 
mouse ovary, estrogen regulates oocyte 
nest dissociation and primordial follicle 
formation by multiple pathways (3). It has 
been suggested that sex differentiation in 
vertebrates is steroid hormones dependent. 
Estrogen plays a critical role in ovarian 
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differentiation. Male sex differentiation 
can occur to the absence of estrogen (4). 
This hormone is associated with 
reproductive organs, mammary gland and 
sexual behavior in female (5). 
Estrogens play important roles and several 
effects on  the ovarian follicle level (6).  
Also,  studies have shown that estrogen 
had protective effects on the follicular 
atresia in the adult mammalian ovaries (7). 
This hormone can regulate the granulosa 
cells proliferation and differentiation, 
increasing the gonadotropin action, 
initiation of gap junctions and acceleration 
of steroidogenesis. In addition, it has 
several extragonadal effects and important 
role in endometrial proliferation and 
biosynthesis of cervical mucus (6). In 
addition, it has been shown that estrogen 
plays basic roles in the regulation of 
follicle/oocyte maturation (8).  
Aromatase, the product of the CYP 19 
gene, is an enzyme complex that catalyzes 
the rate-limiting step in the production of 
estrogens. The conversion of adrenal 
androstenedione to estrogen was 
performed through three hydroxylation 
steps. his enzyme was expressed in some 
tissues such as liver, muscle, fat and ovary 
(9, 10).  
Because aromatase is the terminal step in 
biosynthetic sequence, it can be a good 
target for selective inhibition of estrogen 
biosynthesis. Aromatase inhibitors (AIs) 
have been used in clinical applications 
more than 20 years (11). The studies have 
shown that the use of AIs for adjuvant 
therapy in breast cancer are superior to the 
tamoxifen (9, 12).  
The lack of specificity and the unfavorable 
toxicity profile of first-generation AIs led 
to research for more selective AIs. Third 
generation aromatase inhibitors, including 
anastrozole and letrozole, have been 
approved for the treatment of breast cancer 
(13). Letrozole and anastrozole are two 
main members of non-steroidal AIs (14). 
These aromatase inhibitors have a short 
half-life (approximately 45 hours), few 
side effects, and more potency (15).  
Anastrozole has been approved in North 
America and Europe and is a first selective 
and high potency drug with 96.7% 
aromatase inhibition in subjects receiving 
1mg/day orally (16). 
This study was designed to determine 
whether estrogen is required for follicular 
development in mouse model estrogen 
absence using anastrozole. 
Materials and methods 
All tests were performed according to the 
experimentation at Department of Medical 
Sciences, Tonekabon Branch, Islamic 
Azad University, Tonekabon, Iran. 
In this experimental study, 9 mature male 
and 18 mature female BALB/c mic (15-25 
gr weight, six week age) were housed for 
mating in the 12h light/12h dark cycle and 
controlled temperature (21-22°C). Food 
and water were available for animals 
during the study. The animals were kept 
for three weeks in the laboratory before the 
beginning the experiments. 
After presenting the vaginal plaque, the 
female mice were divided into two groups 
of control and experimental and this day 
was considered as the first day of 
pregnancy. In experimental group, 
anastrozole (50 mg/kg, i.p.) was injected 
on the 14
th
 day of pregnancy. Also, the 
control group was received normal saline 
i.p. any treatment on the 14
th
 day of 
pregnancy.  
After the delivery, 16 female pups were 
separated randomly in each group. In the 
2
nd
, 4
th
 and 7
th
 day after delivery, eight 
pups from each group for age time were 
sacrificed, respectively and the ovaries 
were carefully removed and were fixed in 
the 10% formalin. After tissue processing, 
the 5um sections were prepared and H&E 
staining were performed. The primordial, 
primary and growing follicles were 
counted and compared in each groups.  
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Data analysis  
Data were analyzed by SPSS-16. ANOVA 
test were used for comparing the groups 
and P < 0.05 was considered as significant 
level.  
Results  
The number of primordial, primary and 
growing follicles was compared in the 
control, sham and treated groups.
 
 
Figure 1. The follicular development in the pups from mice treated by anastrozole. (a)  2 day Control group, (b) 
2 day treatment group, blue arrows show the oocytes (H&E staining, 100×). 
 
According to the Figure 1, the 2 day 
ovaries were studied. As showed in this 
photography, oocytes in control groups 
were separated (Figure1a), however in 
treatment group oocytes are in clusters 
(Figure1b). Table 1 shows the number of 
primordial, primary and growing follicles 
in the ovary of five day pups. There wasn‟t 
significant differences in the mean number 
of primordial, primary, growing follicles 
of 4 day pups (P=0.092, P=0.121 and 
P=0.129, respectively, Table 1, Figures 2a 
and 2b). 
  
Table 1. The mean number of primordial, primary and growing follicles in five day pup. The comparison 
between control, sham and treated groups.  
 Control Treatment P value 
Primordial 
follicles 
4
th
  day  15.65±2.35 13.56±2.89 0.092 
7
th
 day 19.24±3.21 17.32±3.12 0.076 
Primary follicles 4
th
  day  10.56±3.76 11.76±3.71 0.121 
7
th
 day 13.24±3.4 14.32±3.13 0.099 
Growing follicles 4
th
  day  3.56±2.61 3.56±2.6 0.129 
7
th
 day 6.24±2.49 5.61±2.13 0.136 
 
In addition, There wasn‟t significant 
differences in the mean number of 
primordial, primary, growing follicles pf 7 
day pups (P=0.076, P=0.099 and P=0.136, 
respectively, Table 1, Figures 2c and 2d).
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Figure 2. The follicular development in the pups from mice treated by anastrozole. (a)  4 day Control group, (b) 
4 day treatment group, (c) 7 day Control group, (d) 7 day treatment group. (H&E staining, 100×). 
 
Discussion  
Estrogen plays an important role in sexual 
characteristics and essential in sex organ 
development in female (5). It has 
important effect on ovarian follicles 
developments and protect them from 
atresia in adult mammalian ovaries (6, 7). 
In addition, it has been shown that 
estrogen plays basic roles in the regulation 
of follicle/oocyte maturation (8). 
Aromatase is  the last step in biosynthetic 
sequence  and can be a good target for 
selective inhibition of estrogen 
biosynthesis (17). AIs such as anastrozole 
are used for treatment of hormone- 
sensitive breast cancer (13). AIs were used 
for blocking the estrogen biosynthesis in 
animal models (6). In these studies, the 
number of healthy follicles was decreased 
and estrogen presentation in the 
folliculogenesis environment was 
necessary to lead the normal oocyte 
maturation. 
Accordingly, this drug can be used for 
evaluation of estrogen effects on the 
development of ovary.  
In this study, anastrozole was injected into 
the pregnant mice and the number of 
several follicles (Primordial, primary and 
growing follicles) of ovaries was 
compared within the 2, 4 and 7 day pups 
between control and treatment groups. 
According to the results, oocytes were 
observed in clusters in the 2 day pups of 
treatment group. These results indicate that 
Original article                                                               J Bas Res Med Sci 2015; 2(1):42-48 . 
46 
 
maternal anastrozole can affect the 
breakdown of the clusters and formation of 
primordial follicles. 
In addition, it can be suggested that 
maternal estrogen absence can affect these 
processes and estrogen has important role 
in the breakdown of nest. Chronic 
administration of anastrozole decreased 
the capacity of the ovaries and anastrozole 
exposure can affect folliculogenesis at the 
initiation stage. 
Primordial follicles formation is performed 
in a process known as ovarian follicular 
breakdown process.  In this process,  
individual primordial follicles separate 
from „nests‟ of oocytes which have 
complete mitotic proliferation and entered 
into meiosis (18).  However, during nest 
breakdown process, some oocytes 
disappear by apoptosis (19).  
Estrogen presence in follicular fluid had 
important roles in follicular breakdown 
process.   
In addition, Guo et al. (2004) evaluated the 
estrogen deprivation effects on 
follicle/oocyte development in mice. Their 
results showed that estrogen plays basic 
roles in the regulation of follicle/oocyte 
maturation (8). 
In this study mice were used as a model of 
ovarian follicular development.  In 
rodents, nest breakdown process  occurs 
after their birth (18, 20). Accordingly, 
rodents are suitable models for studying 
the external materials on ovarian follicular 
development. 
Because of Anastrozole quick effects on 
estrogen production, is a selective anti-
hormonal treatment for the hormone 
dependent breast cancers in 
postmenopausal women (21). Anastrozole 
can reduce the level of estrogen by 
inhibiting the conversion of androgen to 
estrogen (22).  
Steroidal products present in high levels in 
the follicular fluid, during the follicular 
phase and its role in oocyte maturation and 
embryo development is unknown (6).   
Roshangar et al. (2010) evaluated the 
maternal tamoxifen effects on the neonatal 
oocyte differentiation. In their study, 
tamoxifen was used to study the estrogen 
deprivation effects on the ovarian 
follicular development. Their result 
showed that in the 2 day pups oocytes 
were in the cluster formation (23). Their 
results confirm the results of present study. 
In addition, Fatum et al. (2006) evaluated 
the anastrozole effect on the 3-4 weeks 
mice. Their results showed that estrogen 
couldn‟t effect on  folliculogenesis and it 
might be an  independent process (6). 
The results of present study showed the 
treatment of the mothers with anastrozole 
and the absence of estrogen can‟t effect on 
the development of follicles in 4 and 7 day 
pups. This study was designed on 
histological findings in different days of 
birth and the molecular change weren‟t 
considered. According to the results, it is 
suggested that after birth the development 
of ovaries in mice can be affected by the 
neonatal estrogen. Therefore, the 
differences were not observed. However, 
the deprivation of estrogen can effect on 
ovaries and change its regular follicular 
development. 
Dutta et al. (2014) showed that in 
hormonal deprivation, maternal estradiol 
remain high and showed that neonatal 
ovaries were the source of hormones. 
However, in late fetal phases, the 
production of hormones stopped (24).  
In several studies, the effect of different 
aromatase inhibitors was evaluated. 
Zelinski-Wooten et al. showed that the 1, 
4, 6-androstatrien-3, 17-dione (ATD; 
Steraloids, Wilton, NH) could reduce the 
estradiol levels during the late follicular 
phase. However, the total number of 
follicles was not changed (25). 
In other study conducted by Moudgal et al. 
(1995), fadrozole as an aromatase inhibitor 
was evaluated in hamster, rabbits and 
monkeys. Their results showed that 
fadrozole couldn‟t affect the normal and 
hCG/LH-induced ovulations  in these 
types of animals (26). However, 
Roshangar et al. (2010) showed that  
estrogen deprivation could effect on the 
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follicular number and diameter  in the 3, 6 
and 7 day old litters and chronic 
administration of tamoxifen the could 
decrease the number and diameter of 
oocytes and dramatically increased the 
ratio of primordial follicles to primary 
follicles they suggested that such 
tamoxifen exposure could suppress the 
ovarian functional capacity (23). The 
result of this study was in contrast with the 
results of present study in older pups. 
Conclusion 
According to the studies, estrogen is 
necessary for oocyte maturation and 
follicular breakdown and blocking it with 
an aromatase inhibitor, like anastrozole, 
can reduce the primordial follicles. 
However, maternal anastrozole and 
estrogen depression couldn‟t effect on the 
histology of ovarian follicle in neonatal 
mouse.
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